Abstract:Objective. The study is aimed at evaluating the immune-activation state before and after treatment in patients with first-episode depressive disorder (FDD) with evaluating the ILs and CRP levels and further clarifying the association between autoimmunity and the etiology and pathogenesis of FDD. Methods. We designed a case-control study. FDD patients and healthy subjects were enrolled in the FDD group and control group. Serum IL-6, IL-17, and CRP were measured before and after selective serotonin reuptake inhibitor (SSRI) therapy, as well as Hamilton rating scale for depression (HAMD) and life event scale (LES) scores. The correlations between IL-6 and IL-17 and HAMD and LES scores were analysed, and multiple linear regression analysis was performed for HAMD score. Results. 40 FDD patients and 40 healthy subjects were included in the FDD and control group from October 2009 to September 2012. Before treatment, the IL-6 ( 28.99 ± 5.51 , P < 0.001 ) and IL-17 ( 41.15 ± 4.80 , P < 0.001 ) in the FDD group were significantly higher than the control group ( 16.84 ± 3.78 and 21.68 ± 3.72 , respectively). The C-reactive protein (CRP) level in two groups was comparable ( P = 0.879 ). After treatment, the IL-6 ( 18.69 ± 5.07 , P < 0.001 ) and IL-17 ( 30.67 ± 3.47 , P < 0.001 ) levels and HAMD scores ( 6.73 ± 4.15 ) in the FDD group were significantly decreased than before treatment ( P < 0.001 , respectively). CRP level was slightly increased after treatment without statistically significant ( P = 0.239 ). The HAMD score correlated with IL-6 ( r = 0.638 , P < 0.001 ) and IL-17 ( r = 0.927 , P < 0.001 ); the total LES and negative LES also correlated with IL-6 ( r = 0.226 , P < 0.05 ) ( r = 0.366 , P <0.001) and IL-17 ( r = 0.348 , P < 0.001 ) ( r = 0.493 , P < 0.001 ). Multiple linear regression analysis showed that both of the IL-6 and IL-17 had direct impact on HAMD score. Conclusion. The autoimmunity status was overactivated in FDD patients, and serum IL-6 and IL-17 levels had direct impact on the HAMD score. Patients who experienced more negative life events had higher activation level of autoimmunity status and HAMD scores, and serum IL-6 and IL-17 levels can be decreased by SSRI treatment.

Comparisons of Serum Interleukin-8 Levels in Major Depressive Patients With Drug-Free Versus SSRIs Versus Healthy Controls

Linking peripheral IL-6, IL-1 and hypocretin-1 with cognitive impairment from major depression

Association Between Increased Serum Interleukin-8 Levels and Improved Cognition in Major Depressive Patients with SSRIs

Association of Anhedonia with Brain-Derived Neurotrophic Factor and Interleukin-10 in Major Depressive Disorder

Fluoxetine Treatment for Major Depression Decreases the Plasma Levels of Cytokines

Changes in the Serum Levels of Inflammatory Cytokines in Antidepressant Drug-Naïve Patients with Major Depression

Relationship of interleukin 6 with depression

The characteristics of sympathetic skin response in patients with depression

Associations Between Autoimmunity and Depression: Serum IL-6 and IL-17 Have Directly Impact on the HAMD Scores in Patients with First-Episode Depressive Disorder

Relaitonship of mean platelet volume to MDD: a retrospecitve study

The Changes In, and Relationship Between, Plasma Nitric Oxide and Corticotropin‐releasing Hormone in Patients with Major Depressive Disorder

The Study of Level Changes of Serum Cytokine, C-reactive Protein and Zinc in Patients with Depression at Pre- and Post-Treatment of Paroxetine

The Plasma IL-18, MIP-1α, MCP-1, SDF-1 and Rantes in Patients with Majior Depression

Detection of Proinflammatory Cytokines in Serum Samples from Patients with Primary Major Depressive Disorder

Difference in Proinflammatory Cytokines Produced by Monocytes Between Patients with Major Depressive Disorder and Healthy Controls

Levels of Interlukin-2, Interlukin-6 and Its Soluble Receptors in the First Episode Depression of Uygur Patients Before and after Treatment with Venlafaxine

High concentrations of serum interleukin-6 and interleukin-8 in patients with bipolar disorder

Levels of serum interleukin (IL)-6, IL-1beta, tumour necrosis factor-alpha and leptin and their correlation in depression.

Levels of serum interleukin (IL)-6, IL-1β, tumour necrosis factor-α and leptin and their correlation in depression

The relationship between plasma cytokine levels and antidepressant response in patients with first-episode major depressive disorder

TNF-α, IL-6 and hsCRP in patients with melancholic, atypical and anxious depression: an antibody array analysis related to somatic symptoms